# Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness

> **NCT03935854** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 23 (actual)

## Conditions studied

- Obesity
- Ketogenic Dieting
- Metabolic Syndrome
- Bipolar Disorder
- Schizophrenia
- Weight Gain
- Psychotropic Agents Causing Adverse Effects in Therapeutic Use
- Brain Metabolic Disorder

## Interventions

- **OTHER:** LCHF, Ketogenic Diet

## Key facts

- **NCT ID:** NCT03935854
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-13
- **Primary completion:** 2022-08-11
- **Final completion:** 2022-08-11
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03935854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03935854, "Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03935854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
